These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7226712)

  • 1. Pharmacology of enantiomers and (-) p-OH metabolite of indacrinone.
    Vlasses PH; Irvin JD; Huber PB; Lee RB; Ferguson RK; Schrogie JJ; Zacchei AG; Davies RO; Abrams WB
    Clin Pharmacol Ther; 1981 Jun; 29(6):798-807. PubMed ID: 7226712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oral indacrinone with furosemide.
    Irvin JD; Vlasses PH; Huber PB; Ferguson RK; Schrogie JJ; Davies RO
    Clin Pharmacol Ther; 1980 Sep; 28(3):376-83. PubMed ID: 6996896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men.
    Vlasses PH; Rotmensch HH; Swanson BN; Irvin JD; Johnson CL; Ferguson RK
    Pharmacotherapy; 1984; 4(5):272-7. PubMed ID: 6504708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive and biochemical effects of indacrinone enantiomers.
    Jain AK; Michael R; Ryan JR; McMahon FG
    Pharmacotherapy; 1984; 4(5):278-83. PubMed ID: 6504709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomers of indacrinone: a new approach to producing an isouricemic diuretic.
    Blaine EH; Fanelli GM; Irvin JD; Tobert JA; Davies RO
    Clin Exp Hypertens A; 1982; 4(1-2):161-76. PubMed ID: 7074983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio.
    Tobert JA; Cirillo VJ; Hitzenberger G; James I; Pryor J; Cook T; Buntinx A; Holmes IB; Lutterbeck PM
    Clin Pharmacol Ther; 1981 Mar; 29(3):344-50. PubMed ID: 7471605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196).
    Brooks BA; Blair EM; Finch R; Lant AF
    Br J Clin Pharmacol; 1980 Sep; 10(3):249-58. PubMed ID: 7437242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indacrinone: modification of diuretic, uricosuric, and kaliuretic actions by amiloride.
    Ravenscroft PJ; Hall GR; Ahokas JT; Emmerson BT; Tobert JA
    Clin Pharmacol Ther; 1980 Jul; 28(1):45-51. PubMed ID: 7389253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereo-specificity of diuretic receptors in the nephron: a study of the enantiomers of indacrinone (MK-196) in man.
    Brooks BA; Lant AF; McNabb WR; Noormohamed FH
    Ren Physiol; 1984; 7(5):304-10. PubMed ID: 6484299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of enantiomers of indacrinone (MK-196) on cation transport by the loop of Henle and distal tubule studied by microperfusion in vivo.
    Field MJ; Fowler N; Giebisch GH
    J Pharmacol Exp Ther; 1984 Jul; 230(1):62-8. PubMed ID: 6747832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal actions of a uricosuric diuretic, racemic indacrinone, in man: comparison with ethacrynic acid and hydrochlorothiazide.
    Brooks BA; Lant AF; McNabb WR; Noormohamed FH
    Br J Clin Pharmacol; 1984 May; 17(5):497-512. PubMed ID: 6428442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new diuretic that does not reduce renal handling of uric acid in rats, S-8666.
    Yonetani Y; Iwaki K; Ishii M; Harada H
    Jpn J Pharmacol; 1987 Apr; 43(4):399-405. PubMed ID: 3613286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship of a uricosuric diuretic.
    Emmerson BT; Thompson L; Mitchell K
    Adv Exp Med Biol; 1977; 76B():320-7. PubMed ID: 855758
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys.
    Zacchei AG; Dobrinska MR; Wishousky TI; Kwan KC; White SD
    Drug Metab Dispos; 1982; 10(1):20-7. PubMed ID: 6124378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity of indacrinone is stereospecific.
    Rybak LP; Whitworth C
    Hear Res; 1987 Dec; 31(2):169-74. PubMed ID: 3446673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cochlear effects of indacrinone are not altered by penicillin.
    Rybak LP; Whitworth C; Morris C; Scott V; Kanno H
    Hear Res; 1995 May; 85(1-2):122-6. PubMed ID: 7559168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chloride transport inhibition by various types of loop diuretics in fish opercular epithelium.
    Eriksson O; Wistrand PJ
    Acta Physiol Scand; 1986 Jan; 126(1):93-101. PubMed ID: 3953305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium loss as a causative factor for skeletal malformations in rats produced by indacrinone: a new investigational loop diuretic.
    Robertson RT; Minsker DH; Bokelman DL; Durand G; Conquet P
    Toxicol Appl Pharmacol; 1981 Aug; 60(1):142-50. PubMed ID: 7281172
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative acute ototoxicity of loop diuretic compounds.
    Rybak LP; Whitworth C; Scott V
    Eur Arch Otorhinolaryngol; 1991; 248(6):353-7. PubMed ID: 1930985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saluretic and uricosuric effects of (6, 7-dichloro-2-methyl=1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee.
    Fanelli GM; Bohn DL; Scriabine A; Beyer KH
    J Pharmacol Exp Ther; 1977 Feb; 200(2):402-12. PubMed ID: 14250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.